Renal-cell carcinoma--molecular pathways and therapies
- PMID: 17215538
- DOI: 10.1056/NEJMe068263
Renal-cell carcinoma--molecular pathways and therapies
Comment on
-
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.N Engl J Med. 2007 Jan 11;356(2):115-24. doi: 10.1056/NEJMoa065044. N Engl J Med. 2007. PMID: 17215529 Clinical Trial.
-
Sorafenib in advanced clear-cell renal-cell carcinoma.N Engl J Med. 2007 Jan 11;356(2):125-34. doi: 10.1056/NEJMoa060655. N Engl J Med. 2007. PMID: 17215530 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous